• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6802220
Device Problem High Readings (2459)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/09/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that a higher than expected vitros b-hcg result was obtained from a patient sample when tested using vitros b-hcg lot 2610 on a vitros eci immunodiagnostic system.The vitros b-hcg result was higher than expected when compared to negative vitros b-hcg results from the same patient.A definitive cause of the event was not established.However, an instrument issue is the most probable contributor to the event.It was established that the customer was not performing maintenance actions on the instrument correctly and crystallization was detected on signal reagent and well wash metering probes by the ortho ls.Precision tests on the instrument indicating acceptable performance following the event, however, the performance of the instrument was not verified with a precision test around the time of the event.A vitros b-hcg lot 2610 reagent issue cannot be ruled out as a contributor to the event, as no quality control data was available to verify reagent performance.However, ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros b-hcg lot 2610.In addition, pre-analytical sample processing could not be ruled out as a contributing factor as the customer was not following the sample collection device manufacturer¿s recommendation for sample centrifugation.Improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.
 
Event Description
An ortho clinical diagnostics (ortho) laboratory specialist (ls) contacted the ortho technical solution center (tsc) on behalf of a customer to report a higher than expected bhcg ii result obtained from a single patient sample when tested using vitros immunodiagnostics products -hcg ii (b-hcg) reagent pack in combination with a vitros eci immunodiagnostic system.The vitros b-hcg result was higher than expected when compared to negative vitros b-hcg results obtained on a vitros system at another customer site.Vitros b-hcg result of 6100.4 miu/ml versus the expected result of 2.39 miu/ml.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The higher than expected vitros b-hcg result was reported from the laboratory.The outcome of the reported result was for repeat testing to be performed at another facility, which resulted as expected.No treatment was altered, initiated or stopped based on the reported result and ortho has not been made aware of any allegation of patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc.Complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B HCG II REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key10418708
MDR Text Key245926220
Report Number3007111389-2020-00098
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeCI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Other
Type of Report Initial
Report Date 08/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/20/2020
Device Catalogue Number6802220
Device Lot Number2610
Was Device Available for Evaluation? Yes
Date Manufacturer Received07/24/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/07/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-